Carbonic anhydrases (CAs) facilitate renal acidification in the kidney by catalyzing the hydration of CO 2 or the reverse reaction, the dehydration of bicarbonate. 1 The majority of the CA activity in the kidney (B95%) is comprised of cytosolic CAII. 1 CAIV is one of three membrane-associated CA isoforms, 2 the others being CAXII [3] [4] [5] [6] [7] and in rodent species, CAXIV, 8, 9 that account for the remaining CA activity in the kidney. In humans, rabbits, and rodent species CAIV is expressed in the proximal tubule (S24S1bS3) and in distal nephron segments including outer and inner medullary collecting ducts (IMCDs) and a-intercalated cells of the cortical collecting duct. 1 A major role for CAIV in urinary acidification has been demonstrated in studies where inhibition of luminal CA activity eliminates nearly all net bicarbonate reabsorption in the proximal tubule 10 and outer medullary collecting duct from the inner stripe, 11 and in CAII-deficient patients and mice where inhibition of CA activity diminishes renal acid secretion. 12, 13 CAIV is unique among CA isoforms, because it is tethered to the plasma membrane via a glycosylphosphatidylinositol lipid anchor (GPI-anchor). 14, 15 Most GPI-anchored proteins are targeted to the apical membrane of polarized epithelial cells; 16 nevertheless, CAIV immunoreactivity detected with different CAIV antibodies has been observed on the basolateral membranes of proximal tubule segments in human, rabbit and rodent species. 2, 17, 18 Studies from our laboratory have functionally demonstrated in the proximal tubule the existence of a basolateral CA activity that facilitates fluid and bicarbonate absorption. 19 These studies suggested that either a transmembrane form is expressed basolaterally or perhaps that GPI-anchored CAIV is additionally targeted to the basolateral membrane. However, with the recent description of CAXII as a major CA isoform that is expressed on the basolateral membranes of acidifying nephron segments, 4 the molecular identity of the basolaterally expressed CA detected by anti-CAIV antibodies required investigation.
In this study, we characterized the polarity and the molecular form of CAIV immunoreactivity in rabbit kidney cortex and in transfected renal IMCD epithelial cells in culture. Whereas in IMCD cells overexpressing CAIV, a transmembrane form is preferentially expressed on the http://www.kidney-international.org o r i g i n a l a r t i c l e & 2007 International Society of Nephrology basolateral membrane, we found that CAIV is normally expressed on both the apical and basolateral membranes of proximal tubule epithelial cells as a GPI-anchored protein.
RESULTS
Trafficking to the basolateral membrane is an intrinsic property of the CAIV molecule CAIV is tethered to cell membranes via a GPI anchor, and typically GPI-anchored proteins are targeted to the apical membrane of polarized epithelial cells. However, as shown in Figure 1 , immunohistochemical staining of kidney cortex with antibodies to CAIV consistently showed basolateral staining of proximal tubules in addition to apical labeling.
The following experiments were designed to determine whether trafficking to the basolateral membrane of renal epithelial cells is an intrinsic property of the CAIV molecule, as well as to ascertain the molecular form of CAIV that is expressed basolaterally. In initial studies the polarity of CAIV expression in an in vitro culture model of polarized renal epithelial cells was examined. IMCD cells were selected for these studies owing to their ability to form confluent monolayers with high transepithelial resistance. Confluent monolayers of IMCD cells stably transfected with a fulllength CAIV exhibiting transepithelial resistance in the range of 900-1500 Ocm 2 were subjected to apical and basolateral surface biotinylation. Biotinylated proteins were precipitated with streptavidin (SAv)-agarose and levels of CAIV and apically (GP135) or basolaterally (Na þ ,K þ -ATPase) expressed proteins were determined by Western blotting. The results of three independent biotinylation experiments are shown in Figure 2a , where GP135 was precipitated predominantly from cells biotinylated on the apical surface and Na þ ,K þ -ATPase was exclusively precipitated from cells biotinylated on the basolateral side, demonstrating the specificity of apical versus basolateral surface biotinylation. CAIV, on the other hand, was equally precipitated from cells biotinylated on either the apical or basolateral side. These results demonstrated that CAIV was sorted to both apical and basolateral membranes of polarized renal epithelial cells.
Because GPI-anchor attachment results in apical sorting of many proteins in polarized epithelial cells, we examined whether expression of a transmembrane form of CAIV explained basolateral expression of CAIV in transfected IMCD cells. CAIV was subcloned into the pcDNA 3.1 vector (see Figure 2b ), so that CAIV expressed as a transmembrane protein would contain a 6XHis epitope-tag contiguous with Figure 1 | CAIV immunoreactivity is observed on the apical and basolateral membrane of proximal tubules. Paraffin-embedded sections of rabbit kidney were stained with a goat anti-rabbit CAIV antibody (YDQR). The slide was developed with an HRP-conjugated anti-goat antibody utilizing the DAB substrate and counterstained with hematoxylin. Solid arrows indicate apical staining, whereas dashed arrows point to basolateral staining. Original magnification Â 100. Figure 2 | CAIV is expressed on the apical and basolateral membranes of IMCD transfectants. (a) Confluent monolayers of IMCD cells stably transfected with rabbit CAIV were grown on Transwell s permeable supports and surface biotinylated on either the apical or basolateral side. Biotinylated proteins were precipitated from cell lysates with SAv-agarose. Levels of SAv-precipitated apical (GP135), basolateral (Na þ ,K þ -ATPase) proteins, and CAIV were determined by Western blotting. Results of three independent surface biotinylation experiments are shown. (b) Rabbit CAIV was subcloned into the pcDNA 3.1 vector so that CAIV expressed a transmembrane protein containing the V5-6X His epitope tags. Omega (o) and (o þ 2) denote the serine residue at which GPI-anchor attachment occurs and the amino-acid residue that plays a key role in the efficiency of lipid anchor linkage, respectively. (c) Confluent monolayers of IMCD cells stably transfected with rabbit CAIV-pcDNA 3.1 construct were surface biotinylated on the apical or basolateral side. Biotinylated proteins were precipitated from cell lysates with SAv-agarose or V5-His-tagged proteins with Ni-NTA-agarose. Levels of transfected CAIV precipitated by Ni-NTA-agarose were determined by blotting with SAv-HRP, whereas GPI-linked CAIV precipitated with SAv-agarose was determined by blotting with anti-rabbit CAIV (KDNV). Results presented in (c) are representative of two independent experiments. the COOH-terminal tail region. 20 Confluent monolayers (transepithelial cell resistance ranging from 800 to 1000 Ocm 2 ) of IMCD cells stably transfected with CAIV-pcDNA 3.1 were subjected to surface biotinylation on either the apical or basolateral side. In the experiment shown in Figure 2c biotinylated proteins were either precipitated from solubilized membranes with SAv-agarose and precipitated CAIV was detected with anti-CAIV antibody by Western blotting, or alternatively a putative transmembrane form of CAIV (His-tagged CAIV) was precipitated with Ni-nitrilotriacetic acid (NTA)-agarose and subsequently detected by blotting with SAv conjugated to horseradish peroxidase (SAv-HRP). Consistent with the experiment shown in Figure 2a , SAv-agarose precipitated CAIV from membranes subjected to either apical or basolateral surface biotinylation, indicating that CAIV was expressed on both membranes. In contrast, precipitation of a transmembrane form of CAIV with Ni-NTA occurred predominantly from membranes that had been biotinylated on the basolateral side. Results presented in Figure 2c are representative of two independent experiments and indicate that under conditions of high-level expression in polarized renal epithelial cells, a portion of CAIV produced is expressed as a transmembrane protein, and the non-GPIlinked form of CAIV is preferentially targeted to the basolateral membrane.
Antibodies to CAIV detect a 46 kDa protein in both apical and basolateral membranes from kidney cortex
The identity of CAIV immunoreactivity on the basolateral membrane of renal proximal tubules was examined by enrichment of basolateral membranes via Percoll density fractionation of membrane vesicles prepared from kidney cortex. The levels of apical (NHE3) and basolateral (Na þ ,K þ -ATPase) proteins, as well as GPI-anchored proteins (CAIV and alkaline phosphatase) in Percoll gradient fractions were quantified by Western blotting. As shown in Figure 3a , fractions 6-10 were enriched for basolateral membranes, as they contained abundant levels of Na þ ,K þ -ATPase, whereas NHE3 was undetectable. Fractions 11-17 contained NHE3 and alkaline phosphatase and exhibited declining levels of Na þ ,K þ -ATPase, indicating that these latter fractions were enriched for apical membrane vesicles. Antibodies to rabbit CAIV that do not crossreact with CAXII 6 detected a 46 kDa protein across the entire Percoll density gradient, including fractions enriched for basolateral membrane vesicles (6-10); thus, CAIV was present in both apical and basolateral membrane vesicles. This contrasted with another GPI-anchored protein, alkaline phosphatase, which clearly exhibited a distribution consistent with apical expression (Fr. [11] [12] [13] [14] [15] [16] [17] . Figure 3b shows the average and s.d. of four independent membrane vesicle fractionations presented as the percentage of the respective protein total in each Percoll fraction. Note that alkaline phosphatase co-distributed with NHE3, whereas CAIV was consistently detected in basolateral membrane fractions (below 10), characterized by abundant levels of Na þ ,K þ -ATPase and low or undetectable levels of NHE3 and alkaline phosphatase. CAIV in basolateral membrane fractions (below 10) comprised 31.1712.3% of the total CAIV content of the Percoll density gradients. These results confirm that CAIV is expressed on basolateral membranes of the renal proximal tubule.
CAIV expressed on apical and basolateral membranes is equally sensitive to cleavage by PI-PLC
To determine whether CAIV is expressed as a GPI-anchored protein in proximal tubule epithelia, CAIV sensitivity to cleavage by phosphatidylinositol-specific phospholipase C (PI-PLC) was examined. In initial studies total membranes prepared from kidney cortex were subjected to PI-PLC digestion for 1-4 h, and GPI-anchored protein was partitioned from cleaved CAIV by extraction with Triton X-114. Figure 4a shows the result of one such experiment in which the levels of GPI-anchored CAIV in the detergent phase (DG) and cleaved CAIV in the aqueous phase (AQ) were determined by Western blotting. In the absence of PI-PLC digestion most of the CAIV partitions into the DG (89710 %, n ¼ 7). It is important to note that Triton X-114 partitioning does not distinguish between transmembrane and GPI-anchored forms of CAIV, because transmembrane as well as GPI-anchored proteins partition into the DG. Following PI-PLC digestion most, but not all, of the CAIV partitions into the AQ (67714%, n ¼ 7), indicative of removal of the GPI anchor. Despite increasing the length of PI-PLC digestion from 1-4 h, partitioning of CAIV into the AQ never approached 100%. Incomplete release of GPIanchored proteins from membranes following PI-PLC treatment is not uncommon, 21 and possible explanations include sequestration into membrane invaginations, localization in a lipid environment that prevents PI-PLC access, the presence of inside-out vesicles, or attachment of CAIV by a GPI isoform that is resistant to cleavage. Whether or not the PI-PLC insensitive pool (B30%) comprised basolateral membrane resident CAIV was examined by quantifying the PI-PLC sensitivity of CAIV in Percollfractionated membrane vesicles. In the experiment shown in Figure 4b , total membrane vesicles, basolateral membraneenriched fractions (Fr. 6 and 8), or fractions containing increasing amount of apical vesicles (Fr. [10] [11] [12] [13] [14] , were subjected to extensive PI-PLC digestion or left untreated. Cleaved CAIV was separated from the GPI-anchored protein by Triton X-114 partitioning. As noted above, in the absence of PI-PLC digestion CAIV in membrane vesicle fractions partitioned into the DG phase, whereas PI-PLC treatment resulted in increased partitioning to the AQ from all membrane vesicle fractions including fractions enriched from basolateral membranes (Fr. 6 and 8). Figure 4c shows the summary of four independent experiments presented as the fold decrease in partitioning to the DG along with the fold increase AQ partitioning following PI-PLC digestion. The decrease in DG CAIV upon PI-PLC digestion in basolateral fractions 6 and 8 was not significantly different from that observed in apical fractions (12 and 14; P40.39) . Similarly, the PI-PLC induced increase in AQ CAIV in basolateral fractions was not different from apical fractions (P40.32). These data demonstrate that CAIV is expressed on the apical and basolateral membranes of the proximal tubule as a GPI-anchored protein. And as CAXII is not a GPIanchored protein, cleavage by PI-PLC provides additional evidence that the basolaterally expressed protein that was detected by anti-CAIV antibodies is not CAXII.
CAIV is expressed in the kidney cortex as a single molecular weight species GPI-anchor attachment occurs at serine residue 280 of CAIV and results in the removal of 28 amino acids (MW ¼ 2870.1) from the COOH-terminal tail. If CAIV were expressed as both a GPI-anchored and a transmembrane protein, then two molecular species of CAIV differing by B3 kDa should exist in renal epithelial cells. 20 To confirm that CAIV is expressed only as a GPI-anchored protein in the proximal tubule, the molecular weight of CAIV peptides in membrane vesicle fractions isolated from rabbit kidney cortex was examined following removal of N-linked sugars by treatment with N-glycanase. As shown in Figure 5 , in the absence of deglycosylation CAIV exhibits an apparent molecular weight of B46 kDa as determined by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). Treatment of membrane vesicle fractions with N-glycanase reduces the apparent molecular weight by about 10 kDa, demonstrating that in contrast to CAIV in human tissue, CAIV is heavily glycosylated in the rabbit. All of the membrane vesicle fractions, including total membrane vesicles, contained a single molecular weight species of deglycosylated CAIV. Furthermore, there was no apparent difference in the molecular weight (B35-36 kDa) of deglycosylated CAIV from basolaterally enriched fractions (Fr. 6 and 8) compared to fractions containing apical membrane vesicles (Fr. [10] [11] [12] [13] [14] . These findings provide additional support for the conclusion that CAIV is expressed as a GPI-anchored protein on the basolateral membrane of the proximal tubule. And because CAXII exhibits a predicited molecular weight of B40 kDa, it is evident that CAXII is not detected by our antibody against rabbit CAIV.
CAIV accounts for approximately half of the CA activity in basolateral membrane of the rabbit proximal tubule CAXII is another CA isoform that is expressed basolaterally in the proximal tubule. 4 Accordingly, we sought to determine the extent to which CAIV contributes to hydratase activity in basolateral membrane vesicles. Owing to the presence of two disulfide bridges, 22 CAIV is resistant to denaturation by treatment with SDS (0.1-1%), whereas other CA isoforms expressed in the kidney (CAXII, CAII, and CAXIV in rodent species) are denatured by SDS treatment. 6, 23 Therefore, differential sensitivity to denaturation by SDS was used to assess the contribution of CAIV to CA hydratase activity in apical and basolateral membranes of the proximal tubule. CA hydratase activity in membrane preparations was measured by a microassay method, as described by Brion et al. 24, 25 SDS treatment of total membranes prepared from mouse kidney cortex reduced hydratase activity by 83%, indicating that CA isoforms other than CAIV (e.g. CAXII and CAXIV) account for the bulk of membrane-associated CA activity in mouse kidney (Table 1, Figure 6b ). In contrast, 80-86% of the hydratase activity in total membrane vesicles isolated from rabbit kidney cortex was resistant to SDS treatment, in keeping with our previous study. 25 Thus, unlike the mouse, CAIV accounts for most (80-90%) of the membraneassociated CA hydratase activity in the rabbit kidney cortex.
To assess the contribution of CAIV to hydratase activity in apical and basolateral membranes of the proximal tubule, the microassay method was used to measure CA activity in vesicles enriched for basolateral or apical membranes by Percoll density fractionation. As shown in Figure 6a , fractions 6 and 8 contained CAIV-containing vesicles enriched for basolateral membranes, characterized by abundant Na þ ,K þ -ATPase, and virtually undetectable levels of NHE3. In three independent experiments, 40-60% of the hydratase activity in basolateral membranes (Fr. 6 and 8) was resistant to denaturation by SDS, indicating that CAIV accounts for approximately half of the CA hydratase activity in basolateral membranes from rabbit proximal tubule. In contrast, in apical membrane fractions (Fr. [16] [17] [18] , characterized by abundant NHE3 and low level Na, K-ATPase (Figure 6a ), most of the hydratase activity (85-100%) was resistant to SDS (Table 1 and Figure 6b ) (note in Table 1 that in those instances where mean hydratase activity was slightly higher in SDS-treated apical samples compared to untreated samples, (Figure 6a ).
the SDS-resistant activity was deemed to be 100% ( Figure  6b ). Slightly increased CA activity following SDS treatment was typically observed when boiled samples were used as a baseline control (Exp. 1 and 2). When acetazolamide-treated controls were used to establish baseline activity, SDS-resistant activity did not exceed 100% (Exp. 3). The latter result is consistent with the conclusion that CAIV is the only membrane CA isoform expressed apically in the proximal tubule. More importantly, these results indicate that both CAIV and CAXII contribute to basolateral hydratase activity that facilitates bicarbonate reabsorption in the rabbit proximal tubule.
DISCUSSION
The principal finding of this study showed that CAIV was expressed on both the apical and basolateral membranes of polarized renal proximal tubular epithelial cells as a GPIanchored protein. We have confirmed ( Figure 1) the results of immunohistochemical studies 2 by demonstrating that proximal tubule basolateral membranes enriched from kidney cortex contain immunoreactivity that is identical in molecular weight to CAIV in apical membrane fractions ( Figure 5 ). These results rule out the possibility that antibodies to CAIV were crossreacting with another CA isoform (e.g. CAXII) that is expressed in basolateral membranes of the proximal tubule. Approximately half of the basolateral hydratase activity was resistant to SDS denaturation ( Figure 6 ), indicating that it was CAIV. Furthermore, the amount of CAIV in basolateral membrane fractions comprised a substantial portion (B30%) of the total CAIV protein, suggesting that levels of basolaterally expressed CAIV are sufficient for facilitation of acid/base transport in the proximal tubule, as shown in previous functional studies. 19 In addition to CAIV reported herein, carboxypeptidase M and PrP C are two other examples of GPI-anchored proteins that are either targeted to both apical and basolateral membranes (carboxypeptidase M) 26 or are preferentially sorted to basolateral membranes (PrP C ) 27 in MDCK cells. Interestingly, alkaline phosphatase and five other GPIanchored proteins exhibited the expected apical localization. 26 In contrast, in another cell culture model, Fischer rat thyroid epithelial cells, six out of nine detectable endogenous GPI-anchored proteins were localized on the basolateral surface, two were apical and one was not polarized. 28 Accordingly, ours may be the first report demonstrating both apical and basolateral targeting of a GPI-anchored protein in polarized epithelial cells from normal tissue.
Studies utilizing a cell culture model confirmed that apical and basolateral targeting of CAIV is an intrinsic property of the CAIV molecule. CAIV was expressed on both apical and basolateral membranes in transfected IMCD cells (Figure 2a ), a polarized renal epithelial cell line derived from the distal nephron. 29 In the IMCD-transfected model we also found that CAIV expressed as transmembrane protein was preferentially targeted to the basolateral membrane ( Figure 2b ). Basolateral targeting of the transmembrane form of CAIV is consistent with the presence of putative dileucine basolateral sorting motifs within the COOH-terminal tail of CAIV. 20, 30 However, CAIV expressed in basolateral and apical membranes from kidney cortex was equally sensitive to PI-PLC cleavage (Figure 4) , as was shown by McGwire et al. 26 for carboxypeptidase M in MDCK cells, indicating that CAIV is expressed on both membranes as a GPI-anchored protein. Furthermore, we found no evidence for expression of a B3 kDa higher-molecular weight species corresponding to a putative transmembrane form of CAIV in kidney cortex ( Figure 5 ). Expression of a transmembrane CAIV in the IMCD transfectant was most likely due to exceptionally high CAIV expression level driven by the CMV promoter of the pcDNA 3.1 vector, which could have overloaded the capacity of either GPI-anchor attachment or the rate of transmembrane form degradation in the endoplasmic reticulum. 31, 32 Expression of CAIV as a transmembrane protein has been observed in normal pancreatic ducts. Fanjul et al. 33 reported that CAIV expressed on the luminal or apical surface of ductal cells was insensitive to PI-PLC cleavage and was detected by polyclonal antisera raised against the COOH terminal tail that is normally cleaved upon GPI-anchor attachment. Results of this study conflict with our findings in the IMCD transfectant model, where transmembrane CAIV was preferentially targeted to the basolateral membrane (Figure 2b) . The functional significance of transmembrane CAIV is unclear, as cleavage of the COOH-terminal tail of CAIV has been reported to be necessary for realization of full enzyme activity. 34 Mutations of the o site prevented removal of the C-terminal hydrophobic domain, such that the mutated CAIV was inactive, not GPI-anchored, and not expressed on the cell surface. 34 Overall, the results of our study suggest that CAIV has a strong proclivity for trafficking to the basolateral membrane of proximal tubular epithelial cells even in the context of GPI-anchor attachment. It is important to note, however, that in distal nephron segments CAIV expression is detected exclusively on the luminal or apical membrane. 2 Furthermore, CAIV expressed in the rabbit kidney medulla exhibits a distinct glycosylation pattern from CAIV expressed in kidney cortex. 2 Differences in the molecular forms and localization of CAIV in kidney and pancreas suggest that cell-specific post-translational modification and/or trafficking of CAIV occurs in different types of polarized epithelial cells.
Early studies of protein trafficking indicated that GPI anchor attachment targeted proteins to the apical membrane of polarized epithelial cells. It was proposed that apical sorting resulted from segregation of GPI-anchored proteins into membrane microdomains called lipid rafts or detergentresistant membranes that are characterized by their lipid composition (e.g. enriched in cholesterol and sphingolipid content) and resistance to solubilization in non-ionic detergents such as Triton X-100. [35] [36] [37] [38] [39] [40] However, it is now clear that GPI-linkage and raft association alone is not sufficient for apical sorting. Several studies have dissociated apical sorting from raft association, 27, [41] [42] [43] and other sorting determinants such as N-glycans 42, 44 or oligomerization have been shown to exert a greater influence on apical targeting. 45, 46 Furthermore, trafficking of GPI-anchored proteins to the apical membrane can occur via either direct or indirect (transcytotic) pathways. 41, 47, 48 The extent to which N-glycans, protein oligomerization, or possibly other sorting determinants influence basolateral sorting of CAIV in the basolateral membrane has yet to be determined. It is interesting to speculate that CAIV trafficking via the indirect (transcytotic) pathway results in physical association with the sodium bicarbonate transporter, sodium bicarbonate co-transporter 1 (NBC1) and retention of CAIV in the basolateral membrane of the proximal tubule. NBC1 is abundantly expressed in the basolateral membrane of the proximal tubule where sodium-dependent co-transport results in bicarbonate and fluid reabsorption. 49 CAIV has been shown to associate with NBC1 to form the extracellular component of a bicarbonate transport meta-bolon. 50 Previous studies from our laboratory have demonstrated the function of a basolateral, membrane-associated CA in bicarbonate and fluid reabsorption in the proximal tubule segments. 19 Results of the this study showing basolateral expression of CAIV in kidney cortex suggest that GPI-anchored CAIV may facilitate bicarbonate transport by NBC1 in the proximal tubule.
MATERIALS AND METHODS Animals
New Zealand white rabbits were purchased from Hazelton-Dutchland farms (Denver, PA, USA) and maintained on a standard rabbit diet. 2 Adult rabbits (1.8-3.1 kg) were killed by intramuscular injection with xylazine (5 mg/kg) and ketamine (44 mg/kg) followed by an intracardiac injection of pentobarbital (100 mg/kg).
Reagents and antibodies
Recombinant PI-PLC from Bacillus thuringiensis expressed in B. subtilis and N-glycanase (peptide-N-glycosidase F; PNGase F; EC 3.5.1.52) isolated from Escherichia coli expressing a cloned gene from Chryseobacterium (Flavobacterium) meningosepticum were purchased from Prozyme (San Leandro, CA, USA). Polyclonal goat anti-rabbit CAIV peptide antibodies (KDNV and YDQR) were previously produced in our laboratory 2 and found not to crossreact with rabbit CAXII. 6 Monoclonal anti-Na þ ,K þ -ATPase a-1, clone C464.6 (Upstate Cell Signaling Solutions, Lake Placid, NY, USA), and anti-alkaline phosphatase, tissue nonspecific (ab17973, AbCam Inc., Cambridge, MA, USA) were used to identify basolateral and apical GPI-anchored proteins, respectively. Monoclonal anti-NHE3 (Clone MAB3134) raised against the rabbit Na þ /H þ exchanger 3 was purchased from Chemicon International, (Temecula, CA, USA). Monocolonal anti-GP135 antibody was a kind gift from Dr George Ojakian. 51 HRP-conjugated secondary antibodies utilized in this study included donkey anti-mouse, -rabbit, or -goat obtained from Jackson ImmunoResearch, West Grove, PA, USA.
Immunohistochemical staining
Expression of CAIV in kidney sections was visualized by immunostaining as described previously. 2 Briefly, rabbit kidneys were perfusion fixed in periodate-lysine-paraformaldehyde or a non-formaldehyde-based fixative, Prefer (Anatech, Battle Creek, MI, USA). Kidney slices (1-2 mm) were then incubated overnight at 41C in the same fixative used for perfusion fixation. Sections were then rinsed in 70% ethanol, embedded in paraffin, and 4 mm sections were collected on slides (Superfrost þ , VWR Scientific, Piscataway, NY, USA). After deparaffinization and hydration, antigen retrieval was accomplished by heating slides in a microwave for 5 min in 1 mM ethylenediaminetetraacetic acid (EDTA), pH 8. Endogenous peroxidase was quenched by incubating slides in 0.3% H 2 O 2 , and tissue was permeabilized by treatment with 0.3% Triton X-100 in TBS (tris-buffered saline). Slides with blocked with 10% horse serum-TBS, and goat anti-rabbit CAIV (YDQR) antibody was applied at a 1/125 dilution in 5% horse serum-TBS and incubated overnight at 41C. Slides were developed by incubating with biotinylated horse anti-goat secondary (Vector, Burlingame, CA, USA) followed by avidin-biotinylated HRP (Vectastain Elite, Vector Labs, Inc., Burlingame, CA, USA) according to the manufacturer's recommended protocol. Slides were counter-stained with hematoxylin according to recommended protocols (Sigma Diagnostics s , St Louis, MO, USA). Digital Images were produced using the Spot RT color digital camera (Diagnostics Instruments Inc., Sterling Heights, MI, USA) mounted on an Olympus BX51 microscope ( Â 60 brightfield, oil immersion) and the Spot Basic Image Software (Diagnostic Instruments).
IMCD transfectants
Rat IMCD cells 29 were grown in low-glucose Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. 10 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulphonic acid, 2 mM glutamine, penicillin G sodium (100 U/ml)-streptomycin sulfate (100 mg/ml) (Invitrogen, Carlsbad, CA, USA). Full-length CAIV was cloned into the BamHI -Xho I sites of pcDNA3 vector (Invitrogen). In order to facilitate analysis of the molecular form of CAIV expressed on the cell surface of IMCD cells, full-length CAIV was subcloned into the pcDNA3.1 directional Topo s Vector by polymerase chain reaction amplification (forward: ATGCAGC TACTGTTTGC; reverse: TCGGAGGAGGCC GGCCAT primers). The pcDNA3.1 vector contains V5 and 6XHis epitope tags contiguous with the CAIV sequence such that CAIV may be affinity isolated using Ni-NTA beads (see below). Expression vectors were transfected into IMCD cells utilizing either Lipofectamine TM Reagent GIBCO/BRL s or DOTAP liposomal transfection reagent (ROCHE Diagnostics Corp. Indianapolis, IN, USA) according to the manufacturer's recommended protocols. Stable transfectants were generated by selection with 0.8-1 mg/ml G418 2 or 3 days posttransfection.
Biotinylation of apical versus basolateral membrane proteins IMCD transfectants were seeded on polycarbonate Transwell s permeable supports (0.4 mM pore size) at 10 6 /4.67 cm 2 or 10 7 /44 cm 2 . The following day transepithelial resistance was measured with an EVOM TM epithelial voltohmeter (World Precision Instruments, Sarasota, FL, USA). Cells were washed (3 Â ) with ice-cold Dulbecco's phosphate-buffered saline (Invitrogen). Apical biotinlyation was achieved by addition of 2 ml of ice-cold Dulbecco's phosphate-buffered saline containing 0.5 mg/ml Sulfo-NHS-LC-Biotin (Pierce Biotechnology Inc., Rockford, IL, USA) to the apical side (filter top) and 3 ml of Dulbecco's phosphate-buffered saline containing 0.5% bovine serum albumin to the basolateral side below the filter to facilitate quenching of any biotin across the membrane. Conversely, basolateral biotinylation was achieved by reversing the position of the prescribed solutions. Biotinylation reactions were incubated for 30 min at 41C and then terminated by twice washing cells with ice-cold quenching solution (100 mM glycine, Dulbecco's phosphate-buffered saline) followed by incubation with a third rinse of quenching solution for 20 min at 41C.
Precipitation of biotinylated and/or His-tagged proteins
Precipitation of biotinylated proteins with SAv-agarose (Pierce) was performed using IMCD transfectants lysed with ice-cold lysis buffer (1% Triton X-100, 50 mM Tris pH 7.5, 150 mM NaCl, 5 mM EDTA supplemented with Complete s Protease Inhibitor tablets). After 0.5-1 h lysates were clarified by centrifigation at 14 000 Â g for 10 min, and lysates were incubated with SAv-agarose (50-100 ml of packed beads) for 4-16 h with agitation at 41C. Beads were then washed twice with lysis buffer, twice with high salt wash buffer (0.1% Triton X-100, 50 mM Tris pH 7.5, 500 mM NaCl, 5 mM EDTA), and once with 10 mM Tris pH 7.5. His-tagged proteins were precipitated from IMCD transfectants lysed with Ni-NTA lysis buffer (1% Triton X-100, 0.5% deoxycholate, 50 mM NaH 2 PO 4, 300 mM NaCl, 10 mM imidazole, Complete s protease inhibitor tablets without EDTA). Clarified lysates (following centrifugation at 14 000 Â g for 10 min) were incubated with 100 ml packed beads of Ni-NTA-agarose (Invitrogen) 4-16 h at 41C, after which beads were washed thrice with Ni-NTA lysis buffer. Proteins were eluted from beads by addition of equal volume of 2 Â SDS-PAGE sample buffer followed by incubation at 1001C for 5 min.
Isolation of total membranes from kidney cortex Snap-frozen tissue (25-50 mg) was homogenized in ice-cold 1 Â total membrane proteins (TMP) buffer (25 mM Tris-SO 4 pH 7.5, 150 mM NaCl, 1 mM EDTA) supplemented with protease inhibitor cocktail (One Complete R tablet per 25-50 ml buffer; Roche Applied Science, Penzberg, Germany) and then incubated on ice for 30 min. Cellular debris was pelleted by centrifugation at 1000 Â g for 10 min at 41C. Supernatants were recovered and then total membranes were pelleted by centrifugation at 110 000 Â g for 1 h at 41C. The supernatants were decanted and pelleted membranes were resuspended in 100-200 ml TMP buffer. Protein concentration in membrane preparations was determined by the Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA) using bovine serum albumin as a standard.
Fractionation of membrane vesicles isolated from kidney cortex
Basolateral membrane vesicles were enriched from rabbit kidney cortex by Percoll density fractionation as described by Grassl and Aronson. 52 Briefly, kidney cortex (5 g) was initially homogenized with Tekmar TK10 homogenizer in 4 Â (weight/volume) ice-cold hepes-buffered sucrose with EDTA (HBE) (10 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulphonic acid, 250 mM sucrose pH 7.6, supplemented with Complete R Protease Inhibitor tablets) and then Dounce homogenized (30 strokes). Homogenates were clarified by centrifugation at 2500 Â g for 15 min at 41C. The supernatant was collected, and pellets were resuspended in HBE and Dounce homogenized for an additional 20 strokes and centrifuged (2500 Â g for 15 min at 41C). Supernatants were combined and membrane vesicles were pelleted by centrifugation (20 000 Â g) for 20 min. Membrane vesicles (white fluffy layer) were gently resuspended from the pellet by aspiration, centrifuged (20 000 Â g) for 20 min, and then resuspended in less than 1 ml of HBE. Membrane vesicles were Dounce homogenized for five strokes and 0.45 ml were layered over 13.65% Percoll TM (Amersham Biosciences, Piscataway, NJ, USA) in HBE (8.5 ml) and centrifuged (48 000 Â g) for 30 min. This fractionation separates basolateral from apical membrane vesicles. Fractions (0.5-1.0 ml) were collected from Percoll density gradients and washed with five volumes of HBE buffer and stored at À801C until use. Total protein concentration in each fraction was determined by utilizing the BioRad protein assay reagent micro-method and a bovine serum albumin standard according to recommended protocols.
PI-PLC Digestion and Triton X-114 Partitioning
Duplicates of membrane fractions (20-100 mg) were adjusted to 10 mM Tris-HCl, 144 mM NaCl by addition of appropriate volume of 5 Â reaction buffer and B1 mg of PI-PLC was added to one set of duplicates and both sets were incubated overnight at 371C. Following digestion, the sample volume was adjusted to 100-200 ml with ice-cold TBS and 1/5 volume of pre-condensed Triton X-114 (final B2%) was added, mixed by vortexing, and then chilled on ice for 15 min with occasional mixing. Samples were warmed to 371C and then centrifuged (1000 Â g). The upper AQ (cleaved or non-GPI-linked protein) was separated from the DG containing GPI-linked or transmembrane proteins. The DG was twice back extracted with ice-cold TBS to facilitate partitioning of soluble versus membrane-anchored proteins. Proteins were precipitated from the AQ and DGs by TCA-DOC method where 1/100 volume of 2% sodium deoxycholate was added and samples were incubated on ice for 30 min followed by addition of 1/10 volume of 100% TCA and incubated at 41C for 16 h. Samples were then centrifuged (15 000 Â g) for 15 min at 41C, and protein pellets were washed twice with cold acetone, air-dried, and solubilized in 1 Â SDS-PAGE sample buffer.
Deglycosylation of CAIV
Membrane vesicles (15-25 mg total protein) prepared from kidney cortex (see above) were adjusted to 20 mM sodium phosphate, pH 7.5, 0.02% sodium azide, 0.1% SDS, 50 mM b-mercaptoethanol, and denatured by heating at 1001C for 5 min. Samples were allowed to cool to room temperature and then adjusted to 0.75% NP-40. Nglycanase (B2.5 mU) was added and reactions were incubated overnight at 371C. Equal volume of 2 Â sample buffer (100 mM Tris, pH 6.8, 20% glycerol 4% SDS, 50 mM 2-mercaptoethanol, 0.05% bromophenol blue) was added and glycanase-treated samples were again heated at 1001C for 5 min. Proteins were resolved on 10 or 12% SDS-PAGE gels and Western blotted for CAIV as described below.
SDS-PAGE and Western blotting
Proteins were resolved by SDS-PAGE (8, 10, or 12% 37.5:1 Acrylamide/bis-acrylamide; Tris-glycine), and transferred to nitrocellulose membranes (Bio-Rad) utilizing a Panther (HEP-1) semidry electroblotter (Owl Scientific, Cambridge, MA, USA) and Towbin's buffer according to recommended protocols. Membranes were then blocked with 3% casein (EMD chemicals Inc., Gibbstown, NJ, USA) in TBS supplemented with 0.05% Tween 20. Incubations with primary antibodies were carried out in heat-sealable bags with 3 ml of 1% casein TBS supplemented with 0.05% Tween 20 for 16 h at 41C, followed by 3 Â 10 min washes with TBS supplemented with 0.05% Tween 20. Incubations with HRP-conjugated secondary antibodies were carried for 2-4 h at room temperature and followed by 3 Â 10 min washes with TBS supplemented with 0.05% Tween 20 and one wash in TBS. Western blots were developed with ECL TM chemiluminescent substrate (Amersham Biosciences), and chemiluminescence was detected by exposure to Hyperfilm TM (Amersham) for up to 15 min.
Microassay for quantification of CA hydratase activity in membrane fractions
The imidazole-Tris end point assay described by Brion et al. 24, 25 was used to quantify hydratase activity in membrane fractions. Briefly, 50 ml of reaction buffer (20 mM imidazole, 5 mM Tris, and 0.4 mM p-nitrophenol) were added via Hamilton syringe to an equal volume containing 10-30 mg of total membrane protein. Reactions were carried out in 6 Â 50 mm glass tubes. All reagents and samples were chilled on ice, and all reactions were carried in a 01C ice bath. The reaction was continuously bubbled with CO 2 until the solution acidified and the yellow color of p-nitrophenol was no longer detectable. The CO 2 flow rate was adjusted such that the time required for color change by a water control sample was between 65 and 75 s.
Enzyme activity was expressed as EU/mg protein and was determined using the following formula:
CA ðEU=mg proteinÞ ¼ logðB=SÞ=ðprotÞlogð2Þ;
where B is the time (s) for boiled/inactive sample and S is the sample time. The term (prot) denotes milligrams of membrane protein in the sample and log 2 ¼ 0.301. SDS-resistant activity was determined by treating membrane samples with 1-2% SDS for 1 h at room temperature before diluting the sample to B0.1% SDS for analysis. For two of three experiments boiled/inactive sample hydratase activity was determined by the time (s) for a color change in membrane fractions that had been heated at 1001C for 15 min; for the third experiment samples treated with 100 mM acetazolamide established the boiled/inactive baseline time. The time required for color change in boiled samples and acetazolamide-treated samples were essentially equivalent (65-75 s). The baseline values for SDStreated samples were determined from corresponding boiled or acetazolamide-treated samples containing equivalent concentrations of SDS. SDS-resistant activity was divided by the activity with no treatment to provide a percentage of CAIV activity in apical versus basolateral fractions.
Statistics
Data are presented as mean7s.d. Paired and unpaired t-tests were performed using Excel 2003 (Microsoft Corp., Bellvue, WA, USA). Significance was asserted if Po0.05.
